Completed

Oral Corticosteroids Versus Exercises On Treatment Of Frozen Shoulder,

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Corticosteroid

+ Exercise

DrugOther
Who is being recruted

Behavior+2

+ Bursitis

+ Joint Diseases

From 18 to 60 Years
+6 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: January 2022
See protocol details

Summary

Principal SponsorIstanbul University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: January 25, 2022

Actual date on which the first participant was enrolled.

After being informed about the study, all patients giving written informed and meet the inclusion criteria will be randomized a double blind manner in a 1:1 (participant and investigator) to oral corticosteroids or exercise.

Official TitleOral Corticosteroids Versus Exercises On Treatment Of Frozen Shoulder,
NCT05212740
Principal SponsorIstanbul University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

33 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 60 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

BehaviorBursitisJoint DiseasesMotor ActivityMusculoskeletal Diseases

Criteria

3 inclusion criteria required to participate
between ages 18-60 years

loss of passive motion of the glenohumeral joint greater than 25% or 30 in at least 2 directions (flexion, external rotation, and internal rotation) compared with the contralateral side

The pain VAS more than 7 (10 in total)

3 exclusion criteria prevent from participating
bilateral frozen shoulder

rotator cuff tear

previous corticosteroid injection at the affected shoulder within 3 months

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
The participants will receive prednisolone for four weeks.

Group II

Active Comparator
The participants will receive joint mobilization techniques, stretching and home exercise.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 2 locations

Suspended

Istanbul Faculty Medicine

Istanbul, Turkey (Türkiye)Open Istanbul Faculty Medicine in Google Maps
Suspended

İÜC Sağlık Bilimleri Fakültesi

Istanbul, Turkey (Türkiye)
Completed2 Study Centers